Skip to content
healthcare.dev

Fenbendazole 222 MG

NDC 85130-100, Fenbendazole 222 MG, capsule, from B & L Healthcare Products INC.

Product NDC
85130-100
Status
Listed
Labeler
B & L Healthcare Products INC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85130-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FENBENDAZOLE299.35 mg/mol
Package NDCNDC-11Package
85130-100-0185130010001120 CAPSULE in 1 BOTTLE, PLASTIC (85130-100-01) / 222 mol in 1 CAPSULE
85130-100-028513001000290 CAPSULE in 1 BOTTLE, PLASTIC (85130-100-02) / 444 mol in 1 CAPSULE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85130-100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85130-100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85130-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.